CAS 1401682-78-7

Fórmula: C24H20F2N6O3

InChI: InChI=1S/C24H20F2N6O3/c25-17-6-5-15(14-32-19-4-1-3-18(26)20(19)21(33)29-24(32)35)13-16(17)22(34)30-9-11-31(12-10-30)23-27-7-2-8-28-23/h1-8,13H,9-12,14H2,(H,29,33,35)

Chave InChI: VBTUJTGLLREMNW-UHFFFAOYSA-N

SMILES: C1CN(CCN1C2=NC=CC=N2)C(=O)C3=C(C=CC(=C3)CN4C5=C(C(=CC=C5)F)C(=O)NC4=O)F

senaparib

CAS: 1401682-78-7

Pureza: 98%

Ref: IN-DA01V7I9

Senaparib

CAS: 1401682-78-7

Senaparib

Fórmula: C₂₄H₂₀F₂N₆O₃

Pureza: ≥98%

Peso molecular: 478.45

Ref: 54-BUP03103

Senaparib

CAS: 1401682-78-7

Senaparib (IMP4297) is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.

Fórmula: C₂₄H₂₀F₂N₆O₃

Pureza: 99.8%

Cor e Forma: White Solid

Peso molecular: 478.45

Ref: TM-T9593

Senaparib

CAS: 1401682-78-7

Senaparib is a peptide that belongs to the class of inhibitors. It is an inhibitor of ion channels and is used as a research tool. Senaparib has been shown to inhibit the activity of receptor-type protein interactions but not ligand-receptor interactions. Senaparib may be useful in the study of cell biology and pharmacology, but its use in humans is limited due to its lack of specificity. Senaparib inhibits the activity of ion channels by binding to their alpha subunit, which prevents channel opening and closes the channel pore. The efficacy of senaparib has been demonstrated in studies with thrombin receptors, where it inhibited thrombin-induced platelet aggregation by blocking alpha IIb beta 3 integrin function.

Fórmula: C₂₄H₂₀F₂N₆O₃

Pureza: Min. 95%

Peso molecular: 478.5 g/mol

Ref: 3D-BGC68278